Development and Characterization of Poly(ε-caprolactone) Reinforced Porous Hydroxyapatite for Bone Tissue Engineering

Abstract:

Hydroxyapatite (HA) scaffold was fabricated using template method. Secondary phase of poly (ε-caprolactone) (PCL) was then introduced into the porous structure of the HA scaffold by the freeze drying method or the room drying process. Compression test and SEM were done to examine the mechanical properties and the microstructural morphology of the composite scaffolds. It was found that the compressive strength and modulus tend to increase with increasing PCL concentration. HA/PCL scaffolds fabricated under the room drying process exhibited higher compression strength and modulus than HA/PCL scaffolds prepared by the freeze drying method because the porous HA surfaces were completely covered by PCL in the room drying scaffolds. XRD test was also used to study the phase stability of the scaffolds. It was confirmed that there was no chemical reaction between PCL and HA. On overall, the results indicated that the introduction of secondary PCL phases into the porous HA scaffold can improve the low strength and toughness of the pure HA scaffold and the HA/PCL composite scaffolds might be a potential candidate in bone tissue engineering.

• Periodical: Key Engineering Materials (Volumes 529-530)
• Pages: 447-452
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.529-530.447
• Online since: November 2012
• Authors: Yos Phanny, Mitsugu Todo
• Keywords: Bone Regeneration, Composite Material, Mechanical Property, Scaffold

References

[1] K. Whang, K.E. Healy, D.R. Elenz, E.K. Nam, D.C. Tsai, C.H. Thomas, G.W. Nuber, F.H. Glorieux, R. Travers, S.M. Sprague, Engineering Bone Regeneration with Bioabsorbable Scaffolds with Novel Microarchitecture, Tissue Engineering. 5 (1999) 35-51.

DOI: 10.1089/ten.1999.5.35

[2] M.V. Cabañas, J. Peña, J. Román, M. Vallet-Regí, Tailoring vancomycin release from β-TCP/agarose scaffolds, European Journal of Pharmaceutical Sciences. 37 (2009) 249-256.

DOI: 10.1016/j.ejps.2009.02.011

[3] S. Kimakhe, S. Bohic, C. Larrose, A. Reynaud, P. Pilet, B. Giumelli, D. Heymann, G. Daculsi, Biological activities of sustained polymyxin B release from calcium phosphate biomaterial prepared by dynamic compaction: An in vitro study, Journal of Biomedical Materials Research. 47 (1999).

DOI: 10.1002/(sici)1097-4636(199910)47:1<18::aid-jbm3>3.0.co;2-t

[4] C. Castro, C. Évora, M. Baro, I. Soriano, E. Sánchez, Two-month ciprofloxacin implants for multibacterial bone infections, European Journal of Pharmaceutics and Biopharmaceutics. 60 (2005) 401-406.

DOI: 10.1016/j.ejpb.2005.02.005

[5] T. Miyai, A. Ito, G. Tamazawa, T. Matsuno, Y. Sogo, C. Nakamura, A. Yamazaki, T. Satoh, Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis, Biomaterials. 29 (2008) 350-358.

DOI: 10.1016/j.biomaterials.2007.09.040

[6] C. Vitale-Brovarone, E. Verné, L. Robiglio, P. Appendino, F. Bassi, G. Martinasso, G. Muzio, R. Canuto, Development of glass–ceramic scaffolds for bone tissue engineering: Characterisation, proliferation of human osteoblasts and nodule formation, Acta Biomaterialia. 3 (2007).

DOI: 10.1016/j.actbio.2006.07.012

[7] Q.Z. Chen, I.D. Thompson, A.R. Boccaccini, 45S5 Bioglass®-derived glass–ceramic scaffolds for bone tissue engineering, Biomaterials. 27 (2006) 2414-2425.

DOI: 10.1016/j.biomaterials.2005.11.025

[8] J.O. Hollinger, J. Brekke, E. Gruskin, D. Lee, Role of Bone Substitutes, Clinical Orthopaedics and Related Research. 324 (1996) 55-65.

DOI: 10.1097/00003086-199603000-00008

[9] M.C. Azevedo, R.L. Reis, M.B. Claase, D.W. Grijpma, J. Feijen, Development and Properties of Polycaprolaction/Hydroxyapatite Composite biomaterials, Journal of Materials Science: Materials in Medicine. 14 (2003) 103-107.

DOI: 10.1023/a:1022051326282

[10] H. -W. Kim, J.C. Knowles, H. -E. Kim, Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release, Journal of Materials Sience: Materials in Medicine. 16 (2005) 189-195.

DOI: 10.1007/s10856-005-6679-y

[11] A.S. Posner, F. Betts, Synthetic amorphous calcium phosphate and its relation to bone mineral structure, Accounts of Chemical Research. 8 (1975) 273-281.

DOI: 10.1021/ar50092a003

[12] L.L. Hench, Biorceramics: From concept to clinic, Journal of the American Ceramic Society. 74 (1991) 1487-1510.

DOI: 10.1111/j.1151-2916.1991.tb07132.x

[13] T.L. Kitsugi, T. Yamamuro, T. Nakamura, M. Oka, Transmission electron microscopy observations at the interface of bone and four types of calcium phosphate ceramics with different calcium/phosphorus molar ratios, Biomaterials. 16 (1995) 1101-1107.

DOI: 10.1016/0142-9612(95)98907-v

[14] B.M. Tracy, R.H. Doremus, Direct electron microscopy studies of the bone—hydroxylapatite interface, Journal of Biomedical Materials Research. 18 (1984) 719-726.

DOI: 10.1002/jbm.820180702

[15] S.N. Bhaskar, J.M. Brady, L. Getter, M.F. Grower, T. Driskell, Biodegradable ceramic implants in bone: Electron and light microscopic analysis, Oral Surgery, Oral Medicine, Oral Pathology. 32 (1971) 336-346.

DOI: 10.1016/0030-4220(71)90238-6

[16] V. Guarino, F. Causa, P.A. Netti, G. Ciapetti, S. Pagani, D. Martini, N. Baldini, L. Ambrosio, The Role of Hydroxyapatite as Solid Signal on Performance of PCL Porous Scaffolds for Bone Tissue Regeneration, Journal of Biomedical Materials Research Part B: Applied Biomaterials. 86 (2008).

DOI: 10.1002/jbm.b.31055

[17] S.F. Hulbert, F.A. Young, R.S. Mathews, J.J. Klawitter, C.D. Talbert, F.H. Stelling, Potential of ceramic materials as permanently implantable skeletal prostheses, Journal of Biomedical Materials Research. 4 (1970) 433-456.

DOI: 10.1002/jbm.820040309

[18] H. -W. Kim, S. -Y. Lee, C. -J. Bae, Y. -J. Noh, H. -E. Kim, H. -M. Kim, J.S. Ko, Porous ZrO2 bone scaffold coated with hydroxyapatite with fluorapatite intermediate layer, Biomaterials. 24 (2003) 3277-3284.

DOI: 10.1016/s0142-9612(03)00162-5

[19] H. -W. Kim, J.C. Knowles, H. -E. Kim, Hydroxyapatite/poly(ε-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery, Biomaterials. 25 (2004) 1279-1287.

DOI: 10.1016/j.biomaterials.2003.07.003

[20] V. Mouriño, A.R. Boccacinni, Bone tissue engineering therapeutics-controlled drug delivery in three dimensional scaffolds, Journal of the Royal Society Interface. 7 (2010) 209-227.

DOI: 10.1098/rsif.2009.0379